Last reviewed · How we verify

NCT06607718: SERIA

Nutritional and Exercise Intervention in Older Adults Admitted to the Acute Care Unit (SERIA)

Completed NA Last updated 7 August 2025
What this trial tests

NA trial testing Resistance Training in Malnutrition; Protein in 105 participants. Completed in 30 June 2025.

Timeline
11 May 2023
Primary endpoint
30 January 2025
30 June 2025

Quick facts

Lead sponsorFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment105
Start date11 May 2023
Primary completion30 January 2025
Estimated completion30 June 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Who can join

65 and older, any sex, with Malnutrition; Protein or Older. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomised, parallel, single-blind clinical trial. Objectives: to evaluate: the impact of the intervention on nutritional status, body composition, strength, the prevalence of sarcopenia and physical performance at discharge and three months later..

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Resistance Training

Trials testing the same drug.

Other recruiting trials for Malnutrition; Protein

Currently open trials in the same condition.

Other Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06607718.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing